Cuijpers, P, Karyotaki, E, Weitz, E, Andersson, G, Hollon, SD, van Straten, A. The effects of psychotherapies for major depression in adults on remission, recovery and improvement: a meta-analysis. J Affect Disord
2014; 159: 118–26.
Vergunst, FK, Fekadu, A, Wooderson, SC, Tunnard, CS, Rane, LI, Markopoulou, K, et al Longitudinal course of symptom severity and fluctuation in patients with treatment-resistant unipolar and bipolar depression. Psychiatry Res
2013; 207: 143–9.
Fekadu, A, Wooderson, SC, Markopoulo, K, Donaldson, C, Papadopoulos, A, Cleare, AL. What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies. J Affect Disord
2009; 116: 4–11.
Olchanski, N, McInnis Myers, M, Halseth, M, Cyr, PL, Bockstedt, L, Goss, TF, et al The economic burden of treatment-resistant depression. Clin Ther
2013; 35: 512–22.
Greenberg, P, Corey-Lisle, PK, Birnbaum, H, Marynchenko, M, Claxton, A. Economic implications of treatment-resistant depression among employees. Pharmacoeconomics
2004; 22: 363–73.
Schatzberg, AF. Anna-Monika Award Lecture, DGPPN Kongress, 2013: the role of the hypothalamic-pituitary-adrenal (HPA) axis in the pathogenesis of psychotic major depression. World J Bio Psychiatry
2015; 16: 2–11.
Stetler, C, Miller, GE. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med
2011; 73: 114–26.
Schlosser, N, Wolf, OT, Wingenfeld, K. Cognitive correlates of hypothalamic-pituitary-adrenal axis in major depression. Expert Rev Endocrinol Metab
2011; 6: 109–26.
Kirschbaum, C, Hellhammer, DH. Salivary Cortisol in psychobiological research: an overview. Neuropsychobiology
1989; 22: 150–69.
Tak, LM, Cleare, AL, Ormel, J, Manoharan, A, Kok, IC, Wessely, S, et al Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. Biol Psychol
2011; 87: 183–94.
Lipsey, MW, Wilson, DB. Practical Meta-Analysis.
SAGE Publications, 2001.
Borenstein, M, Hedges, LV, Higgins, JPT, Rothstein, HR. Introduction to Meta-Analysis.
DerSimonian, R, Laird, N. Meta-analysis in clinical trials. Control Clin Trials
1986; 7: 177–88.
Egger, M, Smith, GD, Schneider, M, Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ
1997; 315: 629–34.
Duval, S, Tweedie, R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics
2000; 56: 455–63.
Corbishley, MA, Beutler, LE, Quan, S, Bamford, C, Meredith, K, Scogin, F, et al Rapid eye-movement density and latency and dexamethasone suppression as predictors of treatment response in depressed older adults. Curr Ther Res Clin Exp
1990; 47: 846–59.
Gunlicks-Stoessel, M, Mufson, L, Cullen, KR, Klimes-Dougan, B. A pilot study of depressed adolescents' Cortisol patterns during parent-adolescent conflict and response to interpersonal psychotherapy (IPT-A). J Affect Disord
2013; 150: 1125–8.
Thase, ME, Simons, AD, Reynolds CF 3rd. Psychobiological correlates of poor response to cognitive behavior therapy: potential indications for antidepressant pharmacotherapy. Psychopharmacol Bull
1993; 29: 293–301.
Thase, ME, Dube, S, Bowler, K, Howland, RH, Myers, JE, Friedman, E, et al Hypothalamic-pituitary-adrenocortical activity and response to cognitive behavior therapy in unmedicated, hospitalized depressed patients. Am J Psychiatry
1996; 153: 886–91.
Kundermann, B, Strate, P, Hemmeter-Spernal, J, Huber, MT, Krieg, JC, Lautenbacher, S. Mid-term effects of serial sleep deprivation therapy implemented in cognitive-behavioral treatment on the neuroendocrine response to clomipramine in patients with major depression. J Psychiatr Res
2009; 43: 711–20.
Robbins, DR, Alessi, NE, Colfer, MV. Treatment of adolescents with major depression: implications of the DST and the melancholic clinical subtype. J Affect Disord
1989; 17: 99–104.
Holland, JM, Schatzberg, AF, O'Hara, R, Marquett, RM, Gallagher-Thompson, D. Pretreatment Cortisol levels predict posttreatment outcomes among older adults with depression in cognitive behavioral therapy. Psychiatry Res
2013; 210: 444–50.
Rush, AJ. A phase II study of cogntive therapy of depression. In Psychotherapy Research (eds Williams, JBW, Spitzer, RE): 214–34. Guilford Press, 1982.
Mcknight, DL, Nelsongray, RO, Barnhill, J. Dexamethasone suppression test and response to cognitive therapy and antidepressant medication. Behav Ther
1992; 23: 99–111.
Anacker, C, Zunszain, PA, Carvalho, LA, Pariante, CM. The glucocorticoid receptor: pivot of depression and of antidepressant treatment?
2011; 36: 415–25.
Gallagher, P, Malik, N, Newham, J, Young, AH, Ferrier, IN, Mackin, P. Antiglucocorticoid treatments for mood disorders. Cochrane Database Syst Rev
2008; 1: CD005168.
Heim, C, Nemeroff, CB. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry
2001; 49: 1023–39.
McEwen, BS. Mood disorders and allostatic load. Biol Psychiatry
2003; 54: 200–7.
Heim, C, Newport, DJ, Mletzko, T, Miller, AH, Nemeroff, CB. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology
2008; 33: 693–710.
Antonijevic, I. HPA axis and sleep: identifying subtypes of major depression. Stress
2008; 11: 15–27.
Nanni, V, Uher, R, Danese, A. Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. Am J Psychiatry
2012; 169: 141–51.
Williams, JM, Crane, C, Barnhofer, T, Brennan, K, Duggan, DS, Fennell, MJ, et al Mindfulness-based cognitive therapy for preventing relapse in recurrent depression: a randomized dismantling trial. J Consult Clin Psychol
2014; 82: 275–86.